Detalhe da pesquisa
1.
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
Thorax
; 78(9): 882-889, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948586
2.
The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry.
BMC Pulm Med
; 23(1): 154, 2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37138274
3.
Differential diagnostics of interstitial lung diseases.
Vnitr Lek
; 69(3): 193-197, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468315
4.
Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study.
Respir Res
; 23(1): 135, 2022 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35624513
5.
6.
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis.
Respir Res
; 21(1): 11, 2020 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915023
7.
Current diagnosis and therapy in sarcoidosis.
Vnitr Lek
; 66(7): 409-413, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380118
8.
Familial pulmonary fibrosis - guidelines for diagnostics and treatment.
Vnitr Lek
; 66(6): 365-370, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380141
9.
Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry.
Respir Res
; 20(1): 16, 2019 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665416
10.
Phenotypes of organ involvement in sarcoidosis.
Eur Respir J
; 51(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371378
11.
[Extrinsic allergic alveolitis: minimum for clinical practice]. / Exogenní alergické alveolitidy: minimum pro praxi.
Vnitr Lek
; 63(11): 802-806, 2018.
Artigo
em Tcheco
| MEDLINE | ID: mdl-29303282
12.
Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.
Am J Respir Crit Care Med
; 192(6): 727-36, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051272
13.
[Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry]. / Prognostické faktory idiopatické plicní fibrózy (IPF) - analýza Ceského registru IPF.
Cas Lek Cesk
; 155(4): 22-8, 2016.
Artigo
em Tcheco
| MEDLINE | ID: mdl-27481198
14.
Hypersensitivity Pneumonitis: Current Concepts of Pathogenesis and Potential Targets for Treatment.
Am J Respir Crit Care Med
; 200(3): 301-308, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150272
15.
The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry.
Arch Bronconeumol
; 60(2): 80-87, 2024 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38160169
16.
CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC).
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 167(4): 335-339, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36628560
17.
Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.
PLoS One
; 17(9): e0273854, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048805
18.
Interstitial Score and Concentrations of IL-4Rα, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias.
Diagnostics (Basel)
; 11(4)2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33924683
19.
Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment.
Biomed Rep
; 15(5): 87, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589215
20.
Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries.
Front Med (Lausanne)
; 8: 729203, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35004713